OTC · CIK 0001562733
SNYRQ Synergy CHC Corp.
Insider trading from SEC Form 4. Last filing Sep 22, 2025. Close $0.01 on Oct 9, 2026, +43% from the 52-week low and -100% from the high.
Synergy CHC Corp. (SNYRQ) has 9 SEC Form 4 filings on file from 4 insiders, the latest filed on Sep 22, 2025. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
5 open-market trades have been scored at SNYRQ. The newest: Jack Ross (CEO and Chairman) bought $80k of stock on Jun 11, 2025, filed Jul 31, 2025, scored 42 (moderate). The largest of the 5 shown: Jack Ross (CEO and Chairman) bought $2.7M on Oct 24, 2024, scored 58 (moderate).
SNYRQ closed at $0.01 on Oct 9, 2026, 43% above its 52-week low and 100% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Synergy CHC Corp., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Jack Ross CEO and Chairman buy | $80k 27,900 shares | +7% | - | |
| 35Weak | Jack Ross CEO and Chairman buy | $30k 16,100 shares | +4% | - | |
| 31Weak | Jack Ross CEO and Chairman buy | $39k 14,340 shares | +4% | - | |
| 30Weak | Jack Ross CEO and Chairman buy | $11k 5,300 shares | +1% | - | |
| 58Moderate | Jack Ross CEO and Chairman buy | $2.7M 300,000 shares | - | - |
Transactions
The newest 50 of 77 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Alfred Baumeler President | AGrant or award Stock option (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Sep 22, 2025 |
| Sep 18, 2025 | Jaime Fickett Chief Financial Officer | AGrant or award Stock option (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Sep 22, 2025 |
| Sep 18, 2025 | Jack Ross CEO and Chairman | AGrant or award Stock option (right to buy)derivativeindirect: By Kenek Brands Inc. | +750,000 | $0.00 | $0 | 750,000 | Sep 22, 2025 |
| Jun 11, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +900 | $2.19 | $1,971 | 383,507 | Jul 31, 2025 |
| Jun 13, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $2.15 | $215 | 383,607 | Jul 31, 2025 |
| Jun 16, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +450 | $2.28 | $1,026 | 384,057 | Jul 31, 2025 |
| Jun 17, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $2.48 | $248 | 384,157 | Jul 31, 2025 |
| Jun 18, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +600 | $2.23 | $1,338 | 384,757 | Jul 31, 2025 |
| Jun 20, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +10,300 | $2.60 | $27k | 395,057 | Jul 31, 2025 |
| Jun 23, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +400 | $2.61 | $1,044 | 395,457 | Jul 31, 2025 |
| Jun 24, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +600 | $2.63 | $1,578 | 396,057 | Jul 31, 2025 |
| Jun 26, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +650 | $2.55 | $1,658 | 396,707 | Jul 31, 2025 |
| Jun 27, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $2.60 | $260 | 396,807 | Jul 31, 2025 |
| Jun 30, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +2,600 | $2.69 | $6,994 | 399,407 | Jul 31, 2025 |
| Jul 1, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +250 | $3.05 | $763 | 399,657 | Jul 31, 2025 |
| Jul 2, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +3,750 | $3.23 | $12k | 403,407 | Jul 31, 2025 |
| Jul 3, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +1,750 | $3.22 | $5,635 | 405,157 | Jul 31, 2025 |
| Jul 7, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +700 | $3.26 | $2,282 | 405,857 | Jul 31, 2025 |
| Jul 8, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +800 | $3.36 | $2,688 | 406,657 | Jul 31, 2025 |
| Jul 9, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +400 | $3.15 | $1,260 | 407,057 | Jul 31, 2025 |
| Jul 10, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +1,400 | $3.19 | $4,466 | 408,457 | Jul 31, 2025 |
| Jul 11, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +750 | $3.20 | $2,400 | 409,207 | Jul 31, 2025 |
| Jul 22, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +300 | $3.54 | $1,062 | 409,507 | Jul 31, 2025 |
| Jul 24, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +300 | $3.83 | $1,149 | 409,807 | Jul 31, 2025 |
| Jul 25, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +350 | $3.90 | $1,365 | 410,157 | Jul 31, 2025 |
| Jul 29, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +250 | $3.66 | $915 | 410,407 | Jul 31, 2025 |
| Jul 30, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $3.69 | $369 | 410,507 | Jul 31, 2025 |
| Jun 11, 2025 | Knight Therapeutics Inc owner | POpen-market purchase Pre-Funded Common Stock Purchase Warrantderivativeindirect: See footnote | +428,570 | $0.00 | $0 | 428,570 | Jun 13, 2025 |
| Jun 2, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +2,400 | $1.74 | $4,176 | 368,907 | Jun 11, 2025 |
| Jun 3, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +9,400 | $1.77 | $17k | 378,307 | Jun 11, 2025 |
| Jun 4, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +1,600 | $2.07 | $3,312 | 379,907 | Jun 11, 2025 |
| Jun 5, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +800 | $2.03 | $1,624 | 380,707 | Jun 11, 2025 |
| Jun 9, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +700 | $2.17 | $1,519 | 381,407 | Jun 11, 2025 |
| Jun 10, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +1,200 | $2.14 | $2,568 | 382,607 | Jun 11, 2025 |
| Feb 21, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +300 | $4.00 | $1,200 | 347,177 | May 21, 2025 |
| Apr 11, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +300 | $1.84 | $552 | 361,507 | May 21, 2025 |
| Apr 14, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +400 | $1.86 | $744 | 361,907 | May 21, 2025 |
| Feb 24, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +500 | $4.07 | $2,035 | 347,677 | May 21, 2025 |
| Feb 25, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +580 | $3.77 | $2,187 | 348,257 | May 21, 2025 |
| Apr 16, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $2.40 | $240 | 362,007 | May 21, 2025 |
| Apr 21, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +200 | $2.28 | $456 | 362,207 | May 21, 2025 |
| Feb 26, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +200 | $3.78 | $756 | 348,457 | May 21, 2025 |
| Feb 27, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $3.94 | $394 | 348,557 | May 21, 2025 |
| Apr 22, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +600 | $2.45 | $1,470 | 362,807 | May 21, 2025 |
| May 2, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +900 | $2.05 | $1,845 | 363,707 | May 21, 2025 |
| Mar 5, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $3.68 | $368 | 348,657 | May 21, 2025 |
| May 5, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +800 | $2.10 | $1,680 | 364,507 | May 21, 2025 |
| Mar 7, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +200 | $3.52 | $704 | 348,857 | May 21, 2025 |
| May 6, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $1.90 | $190 | 364,607 | May 21, 2025 |
| Mar 10, 2025 | Jack Ross CEO and Chairman | POpen-market purchase Common Stock, par value $0.00001 per share | +100 | $3.67 | $367 | 348,957 | May 21, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Alfred BaumelerPresident
- Jaime FickettChief Financial Officer
- Knight Therapeutics Incowner
- Jack RossCEO and Chairman
Questions about SNYRQ
Answered from the filings on this page, as of the latest one.
Are insiders buying SNYRQ?
No. In the last 90 days no insider at Synergy CHC Corp. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SNYRQ on the open market?
Jack Ross (CEO and Chairman) bought $80k of SNYRQ on Jun 11, 2025 and filed the Form 4 on Jul 31, 2025. InsiderTell scored 42 (moderate).
How many insiders file Form 4 at Synergy CHC Corp.?
4 people have filed a Form 4 at Synergy CHC Corp., among them Alfred Baumeler (President), Jaime Fickett (Chief Financial Officer), Knight Therapeutics Inc (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.